Amedisys, Inc. (AMED)
NASDAQ: AMED · Real-Time Price · USD
89.97
-0.03 (-0.03%)
Nov 20, 2024, 11:28 AM EST - Market open
Amedisys Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 2,321 | 2,236 | 2,223 | 2,214 | 2,072 | 1,956 | Upgrade
|
Revenue Growth (YoY) | 4.19% | 0.59% | 0.41% | 6.88% | 5.93% | 17.63% | Upgrade
|
Cost of Revenue | 1,307 | 1,246 | 1,260 | 1,233 | 1,185 | 1,150 | Upgrade
|
Gross Profit | 1,014 | 990.87 | 962.77 | 980.76 | 886.15 | 805.3 | Upgrade
|
Selling, General & Admin | 787.11 | 780.06 | 754.06 | 711.24 | 668.3 | 607.93 | Upgrade
|
Operating Expenses | 804.68 | 797.81 | 778.99 | 742.14 | 697.1 | 626.35 | Upgrade
|
Operating Income | 208.93 | 193.07 | 183.78 | 238.62 | 189.05 | 178.94 | Upgrade
|
Interest Expense | -32.02 | -31.27 | -22.23 | -9.53 | -11.04 | -14.52 | Upgrade
|
Interest & Investment Income | 6.18 | 3.27 | 0.18 | 0.05 | 0.29 | 0.08 | Upgrade
|
Earnings From Equity Investments | 5.71 | 10.76 | -0.05 | 36.05 | 0.99 | 5.34 | Upgrade
|
Other Non Operating Income (Expenses) | 6.6 | 6.47 | 1.57 | 1.75 | 1.31 | 2.04 | Upgrade
|
EBT Excluding Unusual Items | 195.4 | 182.3 | 163.25 | 266.93 | 180.6 | 171.88 | Upgrade
|
Merger & Restructuring Charges | 45.24 | -36.67 | - | - | - | - | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | -3.01 | - | - | - | Upgrade
|
Asset Writedown | - | - | - | - | -4.15 | -1.47 | Upgrade
|
Other Unusual Items | -106 | -106 | - | 13.3 | 34.37 | - | Upgrade
|
Pretax Income | 134.64 | 39.62 | 160.24 | 280.23 | 210.82 | 170.41 | Upgrade
|
Income Tax Expense | 51.94 | 50.56 | 42.55 | 70.07 | 25.64 | 42.5 | Upgrade
|
Earnings From Continuing Operations | 82.7 | -10.94 | 117.7 | 210.17 | 185.18 | 127.91 | Upgrade
|
Net Income to Company | 82.7 | -10.94 | 117.7 | 210.17 | 185.18 | 127.91 | Upgrade
|
Minority Interest in Earnings | 0.23 | 1.19 | 0.91 | -1.09 | -1.58 | -1.07 | Upgrade
|
Net Income | 82.93 | -9.75 | 118.61 | 209.07 | 183.61 | 126.83 | Upgrade
|
Net Income to Common | 82.93 | -9.75 | 118.61 | 209.07 | 183.61 | 126.83 | Upgrade
|
Net Income Growth | 3031.95% | - | -43.27% | 13.87% | 44.76% | 6.27% | Upgrade
|
Shares Outstanding (Basic) | 33 | 33 | 33 | 33 | 33 | 32 | Upgrade
|
Shares Outstanding (Diluted) | 33 | 33 | 33 | 33 | 33 | 33 | Upgrade
|
Shares Change (YoY) | 1.05% | -0.17% | -0.97% | -0.89% | 0.84% | -1.84% | Upgrade
|
EPS (Basic) | 2.54 | -0.30 | 3.65 | 6.40 | 5.64 | 3.95 | Upgrade
|
EPS (Diluted) | 2.52 | -0.30 | 3.63 | 6.34 | 5.52 | 3.84 | Upgrade
|
EPS Growth | 3058.49% | - | -42.74% | 14.86% | 43.75% | 8.17% | Upgrade
|
Free Cash Flow | 204.37 | 131.57 | 127.12 | 182.59 | 283.62 | 194.11 | Upgrade
|
Free Cash Flow Per Share | 6.21 | 4.04 | 3.89 | 5.54 | 8.53 | 5.88 | Upgrade
|
Gross Margin | 43.67% | 44.31% | 43.31% | 44.30% | 42.78% | 41.18% | Upgrade
|
Operating Margin | 9.00% | 8.63% | 8.27% | 10.78% | 9.13% | 9.15% | Upgrade
|
Profit Margin | 3.57% | -0.44% | 5.34% | 9.44% | 8.86% | 6.49% | Upgrade
|
Free Cash Flow Margin | 8.80% | 5.88% | 5.72% | 8.25% | 13.69% | 9.93% | Upgrade
|
EBITDA | 234.15 | 216.91 | 208.72 | 269.52 | 217.85 | 197.37 | Upgrade
|
EBITDA Margin | 10.09% | 9.70% | 9.39% | 12.17% | 10.52% | 10.09% | Upgrade
|
D&A For EBITDA | 25.22 | 23.85 | 24.94 | 30.9 | 28.8 | 18.43 | Upgrade
|
EBIT | 208.93 | 193.07 | 183.78 | 238.62 | 189.05 | 178.94 | Upgrade
|
EBIT Margin | 9.00% | 8.63% | 8.27% | 10.78% | 9.13% | 9.15% | Upgrade
|
Effective Tax Rate | 38.58% | 127.60% | 26.55% | 25.00% | 12.16% | 24.94% | Upgrade
|
Advertising Expenses | - | 7.2 | 7.3 | 7.4 | 6.5 | 7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.